乳がんの治療における用量応答
T H Stewart1, M W Retsky, S C Tsai
1Ottawa General Hospital, Ontario, Canada.
Lancet (London, England)
|February 12, 1994
まとめ
効果的な乳がん薬は,免疫系のサイトカインを,投与量に依存した方法で減少させます. このサイトカインの減少は,転移性乳がん患者の完全な寛解に寄与する可能性があります.
科学分野:
- 腫瘍学 腫瘍学
- 免疫学 免疫学とは
背景:
- 転移性乳がんの治療は依然として大きな課題です.
- 癌の逆行における免疫系の役割は複雑である.
研究 の 目的:
- 薬剤の投与量,がんの回帰,免疫系のサイトカイン生成との関係を調査する.
- 薬剤の有効性を完全寛解と結びつける潜在的なメカニズムを探求する.
主な方法:
- 転移性乳がんの逆行を引き起こす薬剤の有効性の分析.
- 治療への反応として免疫系によって生成されるサイトカインのレベルを定量化する.
主要な成果:
- 転移性乳がんの逆行に有効な薬剤は,サイトカイン生成の量依存的な減少を示した.
- サイトカイン減少の程度と薬剤の投与量との間には相関関係が見られた.
結論:
- 免疫系サイトカインの薬剤誘発的減少は,完全な寛解を達成する潜在的な要因です.
- この発見は,転移性乳がんの将来の治療戦略に役立つかもしれない.
関連する概念動画
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...


